Indian genericsmaker Ranbaxy Laboratories is on a bit of an expansion binge.
A study conducted by GBI Research predicts that CMO outsourcing in Asia will generate $60 billion in revenues by 2018.
Pfizer ($PFE) will expand in Indonesia ahead of government plans to offer health insurance for some low-income people.
Monteris announced it pulled down $9 million in VC investment this month, aimed to support the continued marketing of the company's neurosurgical ablation tech.
Eleven Biotherapeutics has topped up its bank account with a $20 million injection of venture cash and unveiled a look at the company's lead treatment, EBI-005.
Since the Indian government yanked its exclusivity on the cancer drug, the German company is fighting back.
Despite posting overall financial growth in the first quarter, Covance will eliminate its Chandler, AZ, facility and make cuts to its early development cost structure in an effort to improve profits, the CRO announced.
The Abbott Nutrition R&D Center is an effort between Abbott and Syngene to develop nutritional products, while expanding Abbott's nutrition portfolio at the same time.
By launching what it calls SmartSourcing, the Albany CRMO hopes to provide clients with insourcing and outsourcing opportunities that lead to high-quality performance and scientific expertise without breaking the bank.
An Indian company known for making condoms has completed upgrades on a vaccine plant there and is nearing completion on two others.